Skip to content

Alinity m 09N85-095Recalls & reported problems

Abbott Molecular Inc. · Alinity m BKV AMP Kit · Class 2

All models of Alinity m (13)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00884999050709), received between Sep 23, 2026 and Sep 23, 2026 — classified as 1 malfunction.

The most frequently reported specific device problem is “Low Test Results” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 1 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Low Test Results1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 23, 2026Low Test Results

    The customer reported a misquantitation low result while using the Alinity m BKV assay. The customer stated that their BKV results appear lower when compared to results obtained on another platform; however, they were unable to specify which platform was used for comparison. The customer also indicated that this situation is not considered a discrepancy at this time. The customer stated that the issue was not so much about any one questionable result, but rather an inquiry to demonstrate that the instrument and the assay are performing within expectations. The laboratory manager forwarded an email from the medical director of the Kidney Transplantation from (b)(6) 2026, in which it was stated they were "seeing a worrying trend with biopsy proven polyoma nephropathy with pretty low titers BK PCR performed at DLO/Quest labs (this site). There is a concern that the DLO/Quest PCR is not correlating well with other standard labs. A patient had biopsy proven polyoma nephropathy despite low titers BK PCR. JC PCR is negative. The patient was recently admitted to the hospital and had a BK PCR sent by mistake to ViraCor (another diagnostic company) and the titers were almost 7 times more tha

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50872763 ↗

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page